Claris Lifesciences Ltd.
| BSE: 533288 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE562G01018 |
| BSE 09:19 | 14 Mar | Claris Lifesciences Ltd |
| NSE 05:30 | 01 Jan | Claris Lifesciences Ltd |
| OPEN | 395.10 |
| PREVIOUS CLOSE | 396.05 |
| VOLUME | 1002 |
| 52-Week high | 396.50 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 2,161 |
| Buy Price | 396.05 |
| Buy Qty | 13.00 |
| Sell Price | 396.90 |
| Sell Qty | 100.00 |
Claris Lifesciences Ltd. (CLARISLIFESCIEN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Dr Reddy's Labs | 4701.80 | -10.90 | -0.23 | 13349.10 |
| Aurobindo Pharma | 918.00 | 1.15 | 0.13 | 13266.48 |
| Cipla | 921.80 | 1.50 | 0.16 | 12659.15 |
| Sun Pharma.Inds. | 774.45 | 0.45 | 0.06 | 12531.93 |
| Lupin | 1123.95 | 16.80 | 1.52 | 11055.93 |
| Apollo Hospitals | 4048.35 | 13.95 | 0.35 | 9794.50 |
| Cadila Health. | 591.70 | 5.75 | 0.98 | 7790.40 |
| Alkem Lab | 3483.05 | 28.50 | 0.82 | 7219.68 |
| Glenmark Pharma. | 605.85 | -1.75 | -0.29 | 6712.63 |
| Torrent Pharma. | 3076.35 | 6.65 | 0.22 | 6450.83 |
| Divi's Lab. | 4928.00 | 23.35 | 0.48 | 5310.57 |
| Alembic Pharma | 781.40 | -6.25 | -0.79 | 5051.44 |
| Laurus Labs | 654.35 | 13.70 | 2.14 | 4768.72 |
| Ipca Labs. | 2103.15 | 1.30 | 0.06 | 4337.82 |
| Abbott India | 19748.15 | 662.00 | 3.47 | 4310.02 |
| Glaxosmi. Pharma | 1605.00 | -3.10 | -0.19 | 3193.74 |
| Jubilant Pharmo | 689.40 | 2.40 | 0.35 | 3139.90 |
| Granules India | 383.20 | 3.85 | 1.01 | 3134.98 |
| Sanofi India | 8545.05 | 177.15 | 2.12 | 2901.90 |
| Ajanta Pharma | 2261.30 | -27.80 | -1.21 | 2718.59 |
Quick Links for Claris Lifesciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
